R. Atway

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

P. Choyke, M. Merino, S. Harmon, 2020, medRxiv.

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer

G. Bubley, S. Trostel, S. Balk, 2019, bioRxiv.

A case report of multiple primary prostate tumors with differential drug sensitivity

P. Choyke, M. Merino, S. Harmon, 2020, Nature Communications.